These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 34616409)
21. NEUT-SFL in Patients with COVID-ARDS: A Novel Biomarker for Thrombotic Events? Stiel L; Rabouel Y; Debliquis A; Pointurier V; Mootien J; Kuteifan K Dis Markers; 2021; 2021():4361844. PubMed ID: 34840629 [TBL] [Abstract][Full Text] [Related]
22. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19. Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933 [TBL] [Abstract][Full Text] [Related]
23. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation. Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906 [TBL] [Abstract][Full Text] [Related]
24. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Lesur O; Kokis A; Hermans C; Fülöp T; Bernard A; Lane D Crit Care Med; 2000 Dec; 28(12):3814-22. PubMed ID: 11153619 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia. Liao L; Yang GH J Med Virol; 2021 May; 93(5):2979-2987. PubMed ID: 33506950 [TBL] [Abstract][Full Text] [Related]
35. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. Dentone C; Vena A; Loconte M; Grillo F; Brunetti I; Barisione E; Tedone E; Mora S; Di Biagio A; Orsi A; De Maria A; Nicolini L; Ball L; Giacobbe DR; Magnasco L; Delfino E; Mastracci L; Mangerini R; Taramasso L; Sepulcri C; Pincino R; Bavastro M; Cerchiaro M; Mikulska M; Bruzzone B; Icardi G; Frisoni P; Gratarola A; Patroniti N; Pelosi P; Bassetti M BMC Infect Dis; 2021 Apr; 21(1):353. PubMed ID: 33858331 [TBL] [Abstract][Full Text] [Related]
36. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM Front Immunol; 2021; 12():691725. PubMed ID: 34248984 [TBL] [Abstract][Full Text] [Related]
37. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279 [TBL] [Abstract][Full Text] [Related]
38. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F; Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170 [TBL] [Abstract][Full Text] [Related]
39. Neutrophils in COVID-19: recent insights and advances. Li J; Zhang K; Zhang Y; Gu Z; Huang C Virol J; 2023 Aug; 20(1):169. PubMed ID: 37533131 [TBL] [Abstract][Full Text] [Related]
40. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]